# US 6,730,476 B1 · Methods of diagnosing early-onset menopause

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,476 B1
- Document ID: US6730476B1
- Status: Granted
- Kind: B1
- Application number: 09/632,657
- Filed: 2000-08-04
- Granted: 2004-05-04
- Earliest claimed: 1999-06-30
- Assignees: Interleukin Genetics, Inc.
- Inventors: Gordon Duff; Kenneth Kornman; Simon van Dijk
- Web page: https://patentgrep.com/patent/US6730476B1

## CPC

- G01N 33/5091: {for testing the pathological state of an organism}
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 17/06: Antipsoriatics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G01N 33/5008: {for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics}
- G01N 33/502: {for testing non-proliferative effects}
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q 2600/172: Haplotypes
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method of predicting whether a subject is predisposed to developing early-onset menopause is provided. The method involves genotyping a patient at the IL-1 gene loci.

## Claims

### Claim 1

A method for determining the predisposition of a subject of Northern European ancestry to early-onset menopause, comprising detecting in said subject IL-1RN (+2018) allele 2, wherein detection of an IL-1RN (+2018) allele 2 in a said subject is predictive of a predispositon to early-onset menopause.

### Claim 2 (depends on 1)

The method of claim 1, wherein detecting said allele comprises allele specific oligonucleotide hybridization.

### Claim 3 (depends on 1)

The method of claim 1, wherein detecting said allele comprises RFLP analysis.

### Claim 4 (depends on 1)

The method of claim 1, wherein detecting said allele comprises amplification of a nucleic acid.

### Claim 5 (depends on 4)

The method of claim 4, wherein said amplification comprises PCR.

### Claim 6 (depends on 4)

The method of claim 4, wherein said amplification comprises using a first oligonucleotide that overlaps a second oligonucleotide, or a complement thereof, selected from the group consisting of:
5′ CTA TCT GAG GAA CAA CCA ACT AGT AGC 3′ (SEQ ID NO:7);
and
5′ TAG GAC ATT GCA CCT AGG GTT TGT 3′ (SEQ ID NO:8).

### Claim 7 (depends on 6)

The method of claim 6, wherein said first oligonucleotide comprises at least ten nucleotides of said second oligonucleotide.
